Topics
Products
-
Wednesday - July 30, 2008
Venous Blood Clot Prevention after Hip or Knee Replacement Surgery:
Bayer’s Novel Anticoagulant Rivaroxaban Submitted for Approval in the U.S.
Rivaroxaban is first oral anticoagulant to achieve superior efficacy over the twice-daily injection of enoxaparin while maintaining low rates of major bleeding / No evidence of safety issues attributable to rivaroxaban after long-term exposure
-
Monday - June 30, 2008
Venous Blood Clot Prevention after Knee and Hip Replacement Surgery:
Rivaroxaban is First Novel Oral Anticoagulant to Significantly Reduce the Composite Outcome of Symptomatic VTE and Death
Rivaroxaban shows superior efficacy to enoxaparin for this clinical outcome with a comparable safety profile / Pre-specified analysis of pooled data from RECORD 1-3 studies involving nearly 10,000 patients
-
Tuesday - June 24, 2008
Bayer concludes supply and licensing agreements for Yasmin® and YAZ® with Barr for the United States
Appeal of court decision invalidating Yasmin patent will continue / Further growth of Bayer’s Women’s Healthcare Business Unit expected
-
Thursday - June 12, 2008
Bayer MaterialScience raises price for MDI
-
Monday - June 2, 2008
New Nexavar® Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology (ASCO) Annual Meeting
-
Friday - May 30, 2008
Prevention of Thromboembolism after Knee Replacement Surgery:
Rivaroxaban One Tablet/Once-Daily Superior to Twice-Daily Injectable Enoxaparin in Preventing Venous Blood Clots after Total Knee Replacement Surgery in Pivotal Phase III Trial
Rivaroxaban is First Oral Anticoagulant to Achieve Superior Efficacy over the Twice-Daily Injection of Enoxaparin while Maintaining Low Major Bleeding Rates / RECORD4 Confirms Results of RECORD1, 2 and 3 / U.S. Submission Planned for mid 2008 / Prof. Turpie: “Rivaroxaban has the potential to revolutionize the way we prevent the formation of dangerous blood clots”
-
Thursday - May 29, 2008
UEFA EURO 2008™:
Soccer ball with goose bumps
New surface structure of the “EUROPASS” was realized with Impranil®
-
Thursday - May 29, 2008
Collaboration with adidas
Bayer MaterialScience sets the ball rolling
The high-performance Impranil® coating takes the lead again at the European Championship
-
Monday - May 26, 2008
Bayer MaterialScience works on materials for robotics
Tidy up? My robot’s done it already!
The wrinkle-free polyurethane skin for service robots
-
Tuesday - May 6, 2008
Bayer Schering Pharma to market new low-dose oral contraceptive YAZ® in Europe
-
Wednesday - April 30, 2008
New production process for natural oil polyols for rigid polyurethane foams
Optimized utilization of renewable raw materials
Promising potential for rigid thermal insulation applications
-
Monday - April 21, 2008
Bayer Challenges Watson and Sandoz U.S. ANDA Filings on Yasmin®
-
Thursday - April 17, 2008
Baycusan® C product line:
Five new ingredients for looking great
Presentation by Dr. Sophie Viala at the In-Cosmetics trade show
-
Wednesday - April 16, 2008
Patent infringement lawsuit against Chinese supplier:
Bayer CropScience to enforce its Mefenpyr patent
Intellectual property (IP) rights are the basis for innovation
-
Tuesday - April 15, 2008
Study on sandwich structures in the construction sector
Translucent design elements for interiors
-
Thursday - April 10, 2008
New polyurethane coatings for catheters, endoscopes and more:
Reduced friction for less pain
Latest research and development results presented at the “ECC Medical Coatings and Adhesives” conference
-
Tuesday - April 8, 2008
Wheelchairs and wheelbarrows run smoothly on tires made of polyurethane foam
No more flat tires
Innovative production technology, long service life
-
Thursday - April 3, 2008
Bayer MaterialScience cooperates with Clariant Masterbatches
Carbon nanotubes for new thermoplastic materials
Long-term cooperation is the goal
-
Tuesday - April 1, 2008
Packaging machinery that’s fully packaged in plastic
The polyurethane integral skin foam is easy to mold, lightweight, robust, heat-resistant and can be processed cost-effectively
-
Friday - March 7, 2008
Bayer MaterialScience improves IMPACT technology for producing polyether polyols
Increased capacity and higher quality
Products are used in raw materials for high-grade polyurethane adhesives and sealants
Search
Publications
Stockholder's Newsletter
Annual Report 2007
Sustainable Development Report 2007
research – The Bayer Scientific Magazine
Publications Overview
Newsletter
Events
Download Center - Selection